Toxin-Antitoxin Systems in Pathogenic Bacteria

Bacterial toxin–antitoxin (TA) systems, which are ubiquitously present in bacterial genomes, are not essential for normal cell proliferation. The TA systems regulate fundamental cellular processes, facilitate survival under stress conditions, have essential roles in virulence and represent potential...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (170 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545612404498
ctrlnum (CKB)5400000000042053
(oapen)https://directory.doabooks.org/handle/20.500.12854/76444
(EXLCZ)995400000000042053
collection bib_alma
record_format marc
spelling Alonso, Juan Carlos edt
Toxin-Antitoxin Systems in Pathogenic Bacteria
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (170 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Bacterial toxin–antitoxin (TA) systems, which are ubiquitously present in bacterial genomes, are not essential for normal cell proliferation. The TA systems regulate fundamental cellular processes, facilitate survival under stress conditions, have essential roles in virulence and represent potential therapeutic targets. These genetic TA loci are also shown to be involved in the maintenance of successful multidrug-resistant mobile genetic elements. The TA systems are classified as types I to VI, according to the nature of the antitoxin and to the mode of toxin inhibition. Type II TA systems encode a labile antitoxin and its stable toxin; degradation of the antitoxin renders a free toxin, which is bacteriostatic by nature. A free toxin generates a reversible state with low metabolic activity (quiescence) by affecting important functions of bacterial cells such as transcription, translation, DNA replication, replication and cell-wall synthesis, biofilm formation, phage predation, the regulation of nucleotide pool, etc., whereas antitoxins are toxin inhibitors. Under stress conditions, the TA systems might form networks. To understand the basis of the unique response of TA systems to stress, the prime causes of the emergence of drug-resistant strains, and their contribution to therapy failure and the development of chronic and recurrent infections, must be known in order to grasp how TA systems contribute to the mechanisms of phenotypic heterogeneity and pathogenesis that will enable the rational development of new treatments for infections caused by pathogens.
English
Medicine bicssc
tuberculosis
toxin-antitoxin systems
bacterial cell death
NAD+
stress-response
toxin–antitoxin system
mazF
type II
toxin
mRNA interferase
X-ray crystallography
cognate interactions
cross-interactions
molecular insulation
antitoxin
TA systems
addiction
anti-addiction
type I toxin–antitoxin system
small protein toxin structure
Fst/Ldr family
toxin–antitoxin
M. tuberculosis
bacteria
pathogenesis
protein–protein interactions
cross-talk
protein interface
tolerance
persistence
cross-resistance
toxin-antitoxin system
PemI/PemK
Klebsiella pneumoniae
toxin–antitoxin systems
toxin activation
antibacterial agents
bacterial persistence
Stenotrophomonas maltophilia
opportunistic pathogen
clinical origin
environmental origin
biofilm
antibiotic resistance
cell wall inhibition
nucleotide hydrolysis
uridine diphosphate-N-acetylglucosamine
n/a
3-0365-0674-8
3-0365-0675-6
Alonso, Juan Carlos oth
language English
format eBook
author2 Alonso, Juan Carlos
author_facet Alonso, Juan Carlos
author2_variant j c a jc jca
author2_role Sonstige
title Toxin-Antitoxin Systems in Pathogenic Bacteria
spellingShingle Toxin-Antitoxin Systems in Pathogenic Bacteria
title_full Toxin-Antitoxin Systems in Pathogenic Bacteria
title_fullStr Toxin-Antitoxin Systems in Pathogenic Bacteria
title_full_unstemmed Toxin-Antitoxin Systems in Pathogenic Bacteria
title_auth Toxin-Antitoxin Systems in Pathogenic Bacteria
title_new Toxin-Antitoxin Systems in Pathogenic Bacteria
title_sort toxin-antitoxin systems in pathogenic bacteria
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (170 p.)
isbn 3-0365-0674-8
3-0365-0675-6
illustrated Not Illustrated
work_keys_str_mv AT alonsojuancarlos toxinantitoxinsystemsinpathogenicbacteria
status_str n
ids_txt_mv (CKB)5400000000042053
(oapen)https://directory.doabooks.org/handle/20.500.12854/76444
(EXLCZ)995400000000042053
carrierType_str_mv cr
is_hierarchy_title Toxin-Antitoxin Systems in Pathogenic Bacteria
author2_original_writing_str_mv noLinkedField
_version_ 1759318949889048577
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04083nam-a2200865z--4500</leader><controlfield tag="001">993545612404498</controlfield><controlfield tag="005">20230221123318.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202201s2021 xx |||||o ||| eneng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000042053</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/76444</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000042053</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Alonso, Juan Carlos</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Toxin-Antitoxin Systems in Pathogenic Bacteria</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (170 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Bacterial toxin–antitoxin (TA) systems, which are ubiquitously present in bacterial genomes, are not essential for normal cell proliferation. The TA systems regulate fundamental cellular processes, facilitate survival under stress conditions, have essential roles in virulence and represent potential therapeutic targets. These genetic TA loci are also shown to be involved in the maintenance of successful multidrug-resistant mobile genetic elements. The TA systems are classified as types I to VI, according to the nature of the antitoxin and to the mode of toxin inhibition. Type II TA systems encode a labile antitoxin and its stable toxin; degradation of the antitoxin renders a free toxin, which is bacteriostatic by nature. A free toxin generates a reversible state with low metabolic activity (quiescence) by affecting important functions of bacterial cells such as transcription, translation, DNA replication, replication and cell-wall synthesis, biofilm formation, phage predation, the regulation of nucleotide pool, etc., whereas antitoxins are toxin inhibitors. Under stress conditions, the TA systems might form networks. To understand the basis of the unique response of TA systems to stress, the prime causes of the emergence of drug-resistant strains, and their contribution to therapy failure and the development of chronic and recurrent infections, must be known in order to grasp how TA systems contribute to the mechanisms of phenotypic heterogeneity and pathogenesis that will enable the rational development of new treatments for infections caused by pathogens.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tuberculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxin-antitoxin systems</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacterial cell death</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NAD+</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stress-response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxin–antitoxin system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mazF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">type II</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mRNA interferase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">X-ray crystallography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cognate interactions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cross-interactions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular insulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antitoxin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TA systems</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">addiction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-addiction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">type I toxin–antitoxin system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">small protein toxin structure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Fst/Ldr family</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxin–antitoxin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">M. tuberculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein–protein interactions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cross-talk</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein interface</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tolerance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">persistence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cross-resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxin-antitoxin system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PemI/PemK</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Klebsiella pneumoniae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxin–antitoxin systems</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxin activation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibacterial agents</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacterial persistence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Stenotrophomonas maltophilia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">opportunistic pathogen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical origin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">environmental origin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biofilm</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell wall inhibition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nucleotide hydrolysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uridine diphosphate-N-acetylglucosamine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">n/a</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0674-8</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0675-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alonso, Juan Carlos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-03-03 04:07:54 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337956240004498&amp;Force_direct=true</subfield><subfield code="Z">5337956240004498</subfield><subfield code="8">5337956240004498</subfield></datafield></record></collection>